Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Perth
Clinical trial register · Australia

Clinical Trials in Perth, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3379 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:18 UTC
3379
Studies in scope
all four open statuses
1825
Recruiting now
open to new participants
783
Lead sponsors
across recruiting studies
Top sites
East Melbourne 2 Perth 2 Sydney 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Children's Oncology Group23 National Cancer Institute (NCI)14 Eli Lilly and Company11 AbbVie10 Nationwide Children's Hospital7 AstraZeneca7 Merck Sharp & Dohme LLC6 Janssen Research & Development, LLC5 Hoffmann-La Roche5 Telethon Kids Institute5 Genmab5 Loxo Oncology, Inc.4 Ascentage Pharma Group Inc.4 Murdoch Childrens Research Institute4 Atridia Pty Ltd.3 University of Birmingham3 Telix Pharmaceuticals (Innovations) Pty Limited3 Medtronic Vascular3 Celgene3 Monash University3 The University of Western Australia3 University of Melbourne2 Bristol-Myers Squibb2 BeOne Medicines2 LaNova Medicines Limited2 Neurotech Pharmaceuticals2 RayzeBio, Inc.2 DePuy Orthopaedics2 Novartis Pharmaceuticals2 Australian & New Zealand Children's Haematology/Oncology Group2 Thomas Riva2 Daiichi Sankyo2 Treeline Biosciences, Inc.2 GlaxoSmithKline2 Hummingbird Bioscience2 Bambusa Therapeutics2 Uppsala University2 Takeda2 ResMed2 Regeneron Pharmaceuticals2 Sanofi2 Australian and New Zealand Intensive Care Research Centre2 The University of Queensland1 Swedish Orphan Biovitrum1 Pierre Fabre Medicament1 Cajal Therapeutics Inc.1 Restera, Inc.1 Wake Forest University Health Sciences1 Stemline Therapeutics, Inc.1 Damora Therapeutics1 DBV Technologies1 Day One Biopharmaceuticals, Inc.1 OncoVerity, Inc.1 University Medical Center Nijmegen1 Åslaug Helland1 MOMA Therapeutics1 Boston Scientific Corporation1 University of Michigan1 Boehringer Ingelheim1 University of Sydney1 Genzyme, a Sanofi Company1 Oticara Australia PTY LTD1 Centervue SpA1 Sanofi Pasteur, a Sanofi Company1 Context Therapeutics Inc.1 VectivBio AG1 Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 Revolution Medicines, Inc.1 Stichting Hemato-Oncologie voor Volwassenen Nederland1 St. Jude Children's Research Hospital1 Longbio Pharma (Suzhou) Co., Ltd.1 HighLife SAS1 Arrowhead Pharmaceuticals1 W.L.Gore & Associates1 CSL Behring1 Integrated Haematology and Oncology Network1 Alexion Pharmaceuticals, Inc.1 Nyxoah S.A.1 TORL Biotherapeutics, LLC1 Amgen1 Changi General Hospital1 Melanoma Institute Australia1 Medinol Ltd.1 Yuhan Corporation1 XII Medical1 St. Anna Kinderkrebsforschung1 University Hospital, Antwerp1 Mineralys Therapeutics Inc.1 Grey Wolf Therapeutics1 Princess Maxima Center for Pediatric Oncology1 East Metropolitan Health Service, Australia1 Canadian Cancer Trials Group1 Shanghai Argo Biopharmaceutical Co., Ltd.1 Population Health Research Institute1 Incyte Corporation1 Pfizer1 invoX Pharma Limited1 AP Biosciences Inc.1 ALX Oncology Inc.1 Washington University School of Medicine1 Dizal Pharmaceuticals1 Ellipses Pharma1 4D Molecular Therapeutics1 Intellia Therapeutics1 Shanghai Henlius Biotech1 Vinícius C Quintão, MD, MSc, PhD1 Novo Nordisk A/S1 Kartos Therapeutics, Inc.1 AN2 Therapeutics, Inc1 Apollo Therapeutics Ltd1 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 Editas Medicine, Inc.1 Adlai Nortye Biopharma Co., Ltd.1 Indiana University1 Bausch Health Americas, Inc.1 Lomond Therapeutics Holdings, Inc.1 University Hospitals of Derby and Burton NHS Foundation Trust1 XYone Therapeutics, Inc1 Orygen1 Telix Pharmaceuticals (Innovations) Pty Ltd1 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 ADARx Pharmaceuticals, Inc.1 Lyell Immunopharma, Inc.1 Clover Biopharmaceuticals AUS Pty1 Taiho Pharmaceutical Co., Ltd.1 Iksuda Therapeutics Ltd.1 Beijing InnoCare Pharma Tech Co., Ltd.1 VelaVigo Bio Inc1 Priovant Therapeutics, Inc.1 Arkansas Children's Hospital Research Institute1 Pharvaris Netherlands B.V.1 ViiV Healthcare1 Medtronic MiniMed, Inc.1 ETOP IBCSG Partners Foundation1 Janssen-Cilag Ltd.1 Syndax Pharmaceuticals1 CHDI Foundation, Inc.1 OncoBeta Therapeutics1 Amicus Therapeutics1 University of Colorado, Denver1 University of Alberta1 Nyrada Pty Ltd1 IDEAYA Biosciences1 Sabine Mueller, MD, PhD1 University of Kansas Medical Center1 Caribou Biosciences, Inc.1 Sitala Bio LTD1 Smith & Nephew, Inc.1 Olivia Newton-John Cancer Research Institute1 The University of Texas Health Science Center, Houston1 TrueLab Biopharmaceutical Co., Ltd1 Ukko Inc1 Vascutek Ltd.1 Antares Therapeutics, Inc1 Gustave Roussy, Cancer Campus, Grand Paris1 Lin BioScience, Inc1 Copenhagen University Hospital, Rigshospitalet1 PedAL BCU, LLC1 Epkin1 Sydney Children's Hospitals Network1 Jubilant Therapeutics Inc.1 Immunovant Sciences GmbH1 Erasca, Inc.1 Shanghai Yuguan Biotech Co., Ltd.(Delonix Bioworks)1 University of Pennsylvania1 Eledon Pharmaceuticals1 Rigel Pharmaceuticals1 Clear sponsor filter
Site location
East Melbourne2 Perth2 Sydney2
All 3 locations
Target enrolment
to

Trials with a site in Perth

2 of 3379 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Neurotech Pharmaceuticals
Phase 4
234
East Melbourne, Perth, Sydney
2025-11-21
Recruiting
Neurotech Pharmaceuticals
Phase 3
60
East Melbourne, Perth, Sydney
2025-03-06
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-australia/city/perth

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,379 studies in total at the last sync on 18 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Perth that also match the filters currently applied.

How many clinical trials are recruiting in Perth?

2 of the 2 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Perth), 2 studies
PhaseStudiesRecruitingShare
Phase 31150%
Phase 41150%

Most active sponsors

Lead sponsors with the most studies (Perth)
Lead sponsorStudiesRecruiting
Neurotech Pharmaceuticals22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.